Skip to main content
. Author manuscript; available in PMC: 2018 Jul 15.
Published in final edited form as: Spine (Phila Pa 1976). 2017 Jul 15;42(14):1106–1114. doi: 10.1097/BRS.0000000000002088

Table 4.

Mean change in scores over four years, satisfaction rate, and opioid use*.

Mean Change in Score Compared with Baseline (Standard Error [SE]) or Percent
Difference (95% Confidence interval) P
No Reherniation (n = 730) Reherniation (n = 73)

SF-36 Bodily Pain (BP) (SE)†† 44.9 (0.7) 39.5 (1.7) 5.4 (2.2, 8.6) 0.001
SF-36 Physical Function (PF) (SE)†† 44.5 (0.6) 37.1 (1.5) 7.4 (4.5, 10.3) <0.001
SF-36 Mental Component Summary (MCS)†† 6.6 (0.3) 4.8 (0.7) 1.8 (0.5, 3.1) 0.008
Oswestry Disability Index (ODI) (SE) −38.3 (0.5) −33.9 (1.2) −4.4 (−6.7, −2.1) <0.001
Sciatica Bothersomeness Index (SE)§ −10.5 (0.2) −8.7 (0.5) −1.8 (−2.7, −0.9) <0.001
Very/somewhat satisfied with symptoms (%) 69.1 58.7 10.4 (2.8, 18) 0.008
Opioid use (%) 11.9 11.3 0.6 (−3.6, 4.8) 0.78
*

Scores are adjusted for age, sex, race, marital status, compensation, smoking status, asymmetric sensory decrease, asymmetric motor weakness, work lift demand, herniation location, working status, stomach comorbidity, depression, diabetes, other** comorbidity, self-rated health trend, duration of most recent episode, treatment preference, baseline score (for SF-36, ODI, and Sciatica Bothersomeness Index), and center.

Difference is the difference between no reherniation and reherniation.

††

The SF-36 scores range from 0 to 100, with higher score indicating less severe symptoms.

The Oswestry Disability Index ranges from 0 to 100, with lower scores indicating less severe symptoms.

§

The Sciatica Bothersomeness index range from 0 to 24, with lower scores indicating less severe symptoms.

**

Other comorbidities include: stroke, diabetes, osteoporosis, cancer, fibromyalgia, cfs, PTSD, alcohol, drug dependency, heart, lung, liver, kidney, blood vessel, nervous system, hypertension, migraine, anxiety, stomach, bowel.